A Review of Studies Assessing Cannabidiol’s (CBD) Therapeutic Action and Potentials in Respiratory Diseases

Authors

  • Arwa Fairaq1, Sahar El-Ashmony1,2, Yosra AL-Hindi1

DOI:

https://doi.org/10.37506/mlu.v21i1.2286

Keywords:

CBD, Respiratory, pharmacology, review.

Abstract

Cannabidiol (CBD) is the major non-mind-altering section of the hairy glands of hemp plant that can be named
‘cannabinoids’ (CBs). Cannabinoid in the pharmacology field is becoming an extensive subject specifically
towards the therapeutic characteristics of cannabinoid receptor agonists. Examples such as analgesia,
muscle relaxation, immunosuppressive, antiinflammatory and anti-allergic effects, mood improvement,
appetite stimulation, antiemesis, lowering of intraocular pressure, bronchodilatation, neuroprotection, and
anti-neoplastic effects. Although this vast knowledge about the therapeutic properties of CBs, their clinical
uses remains a controversy and very limited. However, the focus now has been on CBD that constitutes up
to 40% of the extract of the Cannabis and represents one of the most attractive prospects for therapeutic use
owing to its extraordinary lack of both perceptual and psychoactive behavior. Finally, CBD is regarded as an
important putative lead compound to produce cannabinomimetic drugs because of its excellent tolerability
in humans.

Author Biography

Arwa Fairaq1, Sahar El-Ashmony1,2, Yosra AL-Hindi1

1Assistant Professor in Clinical Pharmacy, Faculty of Pharmacy, University of Umm Al-Qura, Makkah, KSA,
2
Faculty of Medicine, Medical Pharmacology Department, Cairo University, Cairo, Egypt

Published

2021-01-09

How to Cite

Arwa Fairaq1, Sahar El-Ashmony1,2, Yosra AL-Hindi1. (2021). A Review of Studies Assessing Cannabidiol’s (CBD) Therapeutic Action and Potentials in Respiratory Diseases. Medico Legal Update, 21(1), 87-91. https://doi.org/10.37506/mlu.v21i1.2286